Integra LifeSciences (IART) News Today $21.90 -0.58 (-2.56%) As of 10:21 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Principal Financial Group Inc. Buys 22,000 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Principal Financial Group Inc. grew its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 5.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 423,432 shares of the life sciences company's stock after bMarch 1 at 3:16 AM | marketbeat.comTruist Financial Remains a Hold on Integra Lifesciences (IART)February 26, 2025 | markets.businessinsider.comBTIG Remains a Hold on Integra Lifesciences (IART)February 26, 2025 | markets.businessinsider.comINTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmFebruary 25, 2025 | globenewswire.comIntegra LifeSciences sees 2025 adjusted EPS $2.41-$2.51, consensus $2.51February 25, 2025 | markets.businessinsider.comIntegra LifeSciences (NASDAQ:IART) Misses Q4 Revenue EstimatesFebruary 25, 2025 | msn.comIntegra LifeSciences Holdings Corporation 2024 Q4 - Results - Earnings Call PresentationFebruary 25, 2025 | seekingalpha.comIntegra LifeSciences (NASDAQ:IART) Updates FY25 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its FY25 earnings guidance. The company provided EPS guidance of $2.41 to $2.51 for the period, compared to the consensus estimate of $2.53.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Issues Q1 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its first quarter earnings guidance. The company provided EPS guidance of $0.40 to $0.45 for the period, compared to the consensus estimate of $0.54.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Posts Earnings Results, Beats Expectations By $0.12 EPSIntegra LifeSciences (NASDAQ:IART - Get Free Report) announced its quarterly earnings results on Tuesday. The life sciences company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.85 by $0.12. The company had revenue of $442.65 million during the quarter, compared to analyst estimates of $445.15 million. Integra LifeSciences had a positive return on equity of 12.35% and a negative net margin of 0.42%. The firm's revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.89 earnings per share.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Releases FY 2025 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.410-2.510 for the period, compared to the consensus estimate of 2.510. The company also issued revenue guidance of $1.7 billionillion-$1.7 billionillion, compared to the consensus estimate of $1.7 billionillion.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Updates Q1 2025 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.400-0.450 for the period, compared to the consensus estimate of 0.560. The company also issued revenue guidance of $375.0 millionillion-$385.0 millionillion, compared to the consensus estimate of $411.7 millionillion.February 25, 2025 | marketbeat.comIntegra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Report Preview: What To ExpectFebruary 25, 2025 | finance.yahoo.comIntegra LifeSciences Holdings Corporation Non-GAAP EPS of $0.97 beats by $0.12, revenue of $442.6M misses by $2.55MFebruary 25, 2025 | seekingalpha.comIntegra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial GuidanceFebruary 25, 2025 | globenewswire.comIntegra LifeSciences (NASDAQ:IART) Stock Price Up 5.1% - Here's WhyIntegra LifeSciences (NASDAQ:IART) Trading Up 5.1% - What's Next?February 24, 2025 | marketbeat.comIntegra LifeSciences (IART) Reports Earnings Tomorrow: What To ExpectFebruary 24, 2025 | finance.yahoo.comIntegra LifeSciences Holdings Corporation Q4 2024 Earnings PreviewFebruary 24, 2025 | seekingalpha.comAccess Investment Management LLC Acquires Shares of 194,715 Integra LifeSciences Holdings Co. (NASDAQ:IART)Access Investment Management LLC acquired a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 194,715 shares of the life sciFebruary 23, 2025 | marketbeat.comLeeward Investments LLC MA Grows Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Leeward Investments LLC MA grew its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 405,506 shares ofFebruary 23, 2025 | marketbeat.comIntegra LifeSciences (IART) to Release Earnings on TuesdayFebruary 23, 2025 | americanbankingnews.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Receives Consensus Recommendation of "Reduce" from AnalystsShares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) have received an average recommendation of "Reduce" from the eight analysts that are covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, four have issuFebruary 20, 2025 | marketbeat.comIntegra LifeSciences (IART) Expected to Announce Earnings on TuesdayIntegra LifeSciences (NASDAQ:IART) will be releasing earnings before the market opens on Tuesday, February 25. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=662100)February 18, 2025 | marketbeat.comShareholders in Integra LifeSciences Holdings (NASDAQ:IART) have lost 63%, as stock drops 4.1% this past weekFebruary 15, 2025 | finance.yahoo.comIntegra LifeSciences (NASDAQ:IART) Stock Price Down 5.3% - Time to Sell?Integra LifeSciences (NASDAQ:IART) Trading Down 5.3% - What's Next?February 12, 2025 | marketbeat.comJan De Witte joins GHO Capital as Operating PartnerFebruary 11, 2025 | globenewswire.comIntegra LifeSciences soars 53% following September Fair Value alertFebruary 9, 2025 | msn.comIntegra LifeSciences (NASDAQ:IART) Share Price Crosses Above 200 Day Moving Average - Should You Sell?Integra LifeSciences (NASDAQ:IART) Share Price Crosses Above 200-Day Moving Average - Here's WhyFebruary 8, 2025 | marketbeat.comNotice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your BehalfFebruary 4, 2025 | globenewswire.comIntegra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025February 4, 2025 | globenewswire.comShort Interest in Integra LifeSciences Holdings Co. (NASDAQ:IART) Declines By 6.1%Integra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 3,240,000 shares, a decline of 6.1% from the December 31st total of 3,450,000 shares. Currently, 4.9% of the company's shares are short sold. Based on an average trading volume of 786,000 shares, the short-interest ratio is currently 4.1 days.February 1, 2025 | marketbeat.comOlstein Capital Management L.P. Sells 22,000 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Olstein Capital Management L.P. cut its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 14.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 133,000 shares of the life sciences company's stocJanuary 26, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Receives Average Rating of "Reduce" from BrokeragesShares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) have been given an average rating of "Reduce" by the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, four havJanuary 26, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Stock Holdings Decreased by Assenagon Asset Management S.A.Assenagon Asset Management S.A. lessened its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 71,464 shares of the life sciences company's stock aJanuary 24, 2025 | marketbeat.comJPMorgan Chase & Co. Trims Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)JPMorgan Chase & Co. trimmed its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 19.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,630 shares of the liJanuary 24, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Short Interest Down 6.1% in DecemberIntegra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 3,240,000 shares, a decrease of 6.1% from the December 15th total of 3,450,000 shares. Based on an average daily trading volume, of 786,000 shares, the days-to-cover ratio is presently 4.1 days. Currently, 4.9% of the shares of the company are short sold.January 19, 2025 | marketbeat.comNotice to Long-Term Integra Lifesciences Holdings Corporation (IART) Shareholders: Grabar Law Investigates Claims on Your BehalfJanuary 17, 2025 | markets.businessinsider.comIntegra LifeSciences launches Integra Institute for HCPsJanuary 14, 2025 | markets.businessinsider.comIntegra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)January 14, 2025 | globenewswire.comBTIG Sticks to Its Hold Rating for Integra Lifesciences (IART)January 13, 2025 | markets.businessinsider.comIntegra Lifesciences (IART) Gets a Hold from BTIGJanuary 8, 2025 | markets.businessinsider.comIntegra LifeSciences reaffirms Q4 revenue view $441M-$451M, consensus $445.15MJanuary 8, 2025 | markets.businessinsider.comWells Fargo Sticks to Its Hold Rating for Integra Lifesciences (IART)January 7, 2025 | markets.businessinsider.comIntegra LifeSciences (NASDAQ:IART) Shares Down 4.4% - Should You Sell?Integra LifeSciences (NASDAQ:IART) Shares Down 4.4% - Here's WhyJanuary 6, 2025 | marketbeat.comIntegra LifeSciences Subsidiary Receives Warning Letter From FDA Related to Quality System Issues >IARTJanuary 6, 2025 | marketwatch.comImplied Volatility Surging for Integra LifeSciences (IART) Stock OptionsJanuary 6, 2025 | msn.comPrincipal Financial Group Inc. Buys 63,266 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Principal Financial Group Inc. lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 18.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 401,432 shares of the life sciences company's stock afJanuary 1, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by AnalystsShares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) have received an average rating of "Reduce" from the eight brokerages that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, fourJanuary 1, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Jane Street Group LLCJane Street Group LLC lessened its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 84.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,813 shares of the life scDecember 30, 2024 | marketbeat.comInsider Stock Buying Reaches US$2.50m On Integra LifeSciences HoldingsDecember 24, 2024 | finance.yahoo.com Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address IART Media Mentions By Week IART Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IART News Sentiment▼0.340.70▲Average Medical News Sentiment IART News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IART Articles This Week▼135▲IART Articles Average Week Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TFX News ITGR News ATRC News ATEC News OFIX News SRDX News ANGO News ARAY News RMTI News RSLS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IART) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IART Stock Alerts